Arkolith/Insider Trading/ZNTL/Form 4

Walters William Thurman

10% OwnerZentalis Pharmaceuticals, Inc. (ZNTL) · full profile →Form 4 · filed Jan 8, 2026
Net Buying
Open-Market Buys
$7.8M
Open-Market Sells
$0
Net Open-Market Flow
$7.8M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 31, 2025Buy(P)6.5M$1.20$7.8M13.5M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-26-002567) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML